BELLICUM PHARMA LIMITED in Reading (South East) entered members' voluntary liquidation, a solvent winding-up. James Hawksworth has been appointed as insolvency practitioner. The case reference is 10415132-mvl. The principal activity of BELLICUM PHARMA LIMITED is research and experimental development on biotechnology.
InsolvencyIndex draws on public sources and makes every effort to keep the content of this page up to date and complete. Despite that care, the content may be incomplete or inaccurate. InsolvencyIndex provides the content of this website "as is", without any warranty as to its soundness, fitness for a particular purpose or otherwise. InsolvencyIndex accepts no liability for loss arising from, or in any way connected with, the use of this website or any inability to consult it. Save as set out in this disclaimer, InsolvencyIndex is not responsible for third-party files linked from this page; linking does not imply any endorsement of those files. Notices reproduced here are extracts from official publications; if you believe an entry is inaccurate, please contact us and we will correct it.